Jay T. Flatley

CIK: 0001189130

Transaction Breakdown

Open Market Buys (P)4 (33.3%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RIVN

Rivian Automotive, Inc. / DE

Director

DNLI

Denali Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

RIVN
Rivian Automotive, Inc. / DE
Jun 22, 2026
Award(A)
Direct
17.4K shares-
DNLI
Denali Therapeutics Inc.
Jun 3, 2026
Award(A)
Direct
6.4K shares-
RIVN
Rivian Automotive, Inc. / DE
Jun 18, 2025
Award(A)
Direct
16.8K shares-
DNLI
Denali Therapeutics Inc.
Jun 3, 2025
Award(A)
Direct
6K shares-
RIVN
Rivian Automotive, Inc. / DE
Apr 17, 2024
Purchase(P)
Direct
1.3K shares at avg. $8.84$11K
RIVN
Rivian Automotive, Inc. / DE
Oct 23, 2023
Sale(S)
Direct
490 shares at avg. $17.07$8K
RIVN
Rivian Automotive, Inc. / DE
Jul 6, 2023
Purchase(P)
Direct
490 shares at avg. $20.67$10K
RIVN
Rivian Automotive, Inc. / DE
Dec 13, 2022
Sale(S)
Direct
3 shares at avg. $24.99$74.97
RIVN
Rivian Automotive, Inc. / DE
Dec 13, 2022
Sale(S)
Direct
57 shares at avg. $25.75$1K
RIVN
Rivian Automotive, Inc. / DE
May 13, 2022
Purchase(P)
Direct
60 shares at avg. $26.83$2K
RIVN
Rivian Automotive, Inc. / DE
Jan 26, 2022
Sale(S)
Direct
30 shares at avg. $62.22$2K
RIVN
Rivian Automotive, Inc. / DE
Jan 11, 2022
Purchase(P)
Direct
30 shares at avg. $82.84$2K

		Type	Shares	Price		Ownership
Jun 22, 2026	RIVN Rivian Automotive, Inc. / DE	Award(A)	17,445	-	$0	Direct
Jun 3, 2026	DNLI Denali Therapeutics Inc.	Award(A)	6,408	-	$0	Direct
Jun 18, 2025	RIVN Rivian Automotive, Inc. / DE	Award(A)	16,812	-	-	Direct
Jun 3, 2025	DNLI Denali Therapeutics Inc.	Award(A)	6,037	-	-	Direct
Apr 17, 2024	RIVN Rivian Automotive, Inc. / DE	Purchase(P)	1,250	$8.84	$11,055	Direct
Oct 23, 2023	RIVN Rivian Automotive, Inc. / DE	Sale(S)	490	$17.07	$8,366	Direct
Jul 6, 2023	RIVN Rivian Automotive, Inc. / DE	Purchase(P)	490	$20.67	$10,131	Direct
Dec 13, 2022	RIVN Rivian Automotive, Inc. / DE	Sale(S)	3	$24.99	$75	Direct
Dec 13, 2022	RIVN Rivian Automotive, Inc. / DE	Sale(S)	57	$25.75	$1,468	Direct
May 13, 2022	RIVN Rivian Automotive, Inc. / DE	Purchase(P)	60	$26.83	$1,610	Direct
Jan 26, 2022	RIVN Rivian Automotive, Inc. / DE	Sale(S)	30	$62.22	$1,867	Direct
Jan 11, 2022	RIVN Rivian Automotive, Inc. / DE	Purchase(P)	30	$82.84	$2,485	Direct

1-12 of 12 transactions

About FLATLEY JAY T

FLATLEY JAY T (SEC CIK 0001189130) files insider reports with the SEC as Director of Rivian Automotive, Inc. / DE (RIVN) and Director of Denali Therapeutics Inc. (DNLI).

Signal8 holds 5 ownership filings by FLATLEY JAY T, all Form 4s, filed between Jun 5, 2025 and Jun 23, 2026. Those filings report 12 transactions, from Jan 11, 2022 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FLATLEY JAY T's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by FLATLEY JAY T

Jun 22, 2026: Grant or award of RIVN shares (Form 4, code A).
Jun 3, 2026: Grant or award of DNLI shares (Form 4, code A).
Jun 18, 2025: Grant or award of RIVN shares (Form 4, code A).
Jun 3, 2025: Grant or award of DNLI shares (Form 4, code A).
Apr 17, 2024: Open-market purchase of RIVN shares (Form 4, code P).

Other insiders filing for Rivian Automotive, Inc. / DE (RIVN)

Mulvey Derek B, Interim CFO
McDonough Claire, Chief Financial Officer
Gomez Aidan N., Director
Schwartz Sanford Harold, Director
Krafcik John, Director
Krawiec Peter, Director

How to read Form 4 transaction codes